CD46 regulates hepatitis B virus entry by modulating cell-surface NTCP levels through cis-interaction
Journal of Molecular Cell Biology · 2025
DOI: 10.1093/jmcb/mjaf055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Cell Biology, 2025. Verfasst von Kei Miyakawa und 9 weiteren Autor:innen. Beteiligte Einrichtung: AIDS Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo 208-0011, Japan. Hauptthemen laut MEDLINE: Organic Anion Transporters, Sodium-Dependent, Symporters, Hepatitis B virus, Virus Internalization. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Takeda Science Foundation.
Abstract (Originalsprache)
Hepatitis B virus (HBV) infection remains a major global health challenge. While sodium taurocholate co-transporting polypeptide (NTCP) is the primary receptor for HBV entry, the molecular mechanisms regulating NTCP-mediated viral entry remain incompletely understood. Here, we identified CD46 as a crucial regulatory factor for NTCP membrane expression. We found that CD46 interacted with NTCP in cis at the plasma membrane through proximity-based labeling screening. The depletion of CD46 significantly reduced cell-surface NTCP levels and HBV infection in hepatocytes. Anti-CD46 monoclonal antibodies, particularly clone E4.3, inhibited HBV infection by triggering NTCP internalization from the plasma membrane to intracellular vesicles. The antiviral effect of CD46 antibodies was also confirmed in primary human hepatocytes. Our study reveals a previously unknown mechanism regulating NTCP-mediated HBV entry and suggests CD46 as a potential therapeutic target for HBV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AIDS Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo 208-0011, Japan.
- Influenza Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo 208-0011, Japan.
- Institute for Vaccine Research and Development, Hokkaido University, Hokkaido 001-0021, Japan.
- Department of Microbiology, Yokohama City University School of Medicine, Kanagawa 236-0004, Japan.
- Department of Bioinformatics and Integrative Omics, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo 208-0011, Japan.
- Life Science Laboratory, Technology and Development Division, Kanto Chemical Co., Inc., Kanagawa 259-1146, Japan.
ORCID-Profile: Koichi Watashi
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
- Takeda Science Foundation
Zitieren
APA
Miyakawa, K., Nakai, Y., Kameya, T., Nishitsuji, H., Watashi, K., Takeda, M., Seya, T., Shimotohno, K., Kimura, Y., & Ryo, A. (2025). CD46 regulates hepatitis B virus entry by modulating cell-surface NTCP levels through cis-interaction. Journal of Molecular Cell Biology. https://doi.org/10.1093/jmcb/mjaf055
Vancouver
Miyakawa K, Nakai Y, Kameya T, Nishitsuji H, Watashi K, Takeda M, et al. CD46 regulates hepatitis B virus entry by modulating cell-surface NTCP levels through cis-interaction. Journal of Molecular Cell Biology. 2025. doi:10.1093/jmcb/mjaf055
BibTeX
@article{Miyakawa2025,
author = {Miyakawa, Kei and Nakai, Yusuke and Kameya, Taichi and Nishitsuji, Hironori and Watashi, Koichi and Takeda, Makoto and Seya, Tsukasa and Shimotohno, Kunitada and Kimura, Yayoi and Ryo, Akihide},
title = {CD46 regulates hepatitis B virus entry by modulating cell-surface NTCP levels through cis-interaction},
journal = {Journal of Molecular Cell Biology},
year = {2025},
doi = {10.1093/jmcb/mjaf055}
}
EUVIMED